Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS selection of Deputy Commissioner Friedman for FDA top spot has some Republican support.

This article was originally published in The Gray Sheet

Executive Summary

HHS ELEVATION OF DEPUTY COMMISSIONER FRIEDMAN TO FDA TOP SPOT has the support of some prominent Republicans with FDA oversight responsibility. Lead Deputy Commissioner Michael Friedman has been identified for some time as HHS Secretary Shalala's top choice to take over the commissioner's job. The Clinton Administration now appears to be comfortable with that choice as well.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel